MBX-2982

DB12345InvestigationalSmall molecule

MBX-2982 has been used in trials studying the treatment of Diabetes.

Mechanism: Pharmacologically active on Glucose-dependent insulinotropic receptor
Curator reviewed
Formula / weight: C₂₂H₂₄N₈OS · 448.55 g/mol (avg)
Code names: MBX-2982

Resolves to

Compound

Structure

InChIKeyNFTMKHWBOINJGM-UHFFFAOYSA-NSMILESCCC1=CN=C(N=C1)N1CCC(CC1)C1=NC(COC2=CC=C(C=C2)N2C=NN=N2)=CS1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with MBX-2982, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.